Does marked systemic hypotension depress coronary thrombolysis induced by intracoronary administration of recombinant tissue-type plasminogen activator?
These results indicate that a moderate increase in coronary inflow pressure increases the rate and extent of coronary thrombolysis compared with values during marked systemic hypotension.
A large majority of Canadians are comfortable with proxy consent for low-risk research. Further work is needed to establish what kinds of research are considered to be low risk.